Cargando…
Hallmarks and Determinants of Oncogenic Translation Revealed by Ribosome Profiling in Models of Breast Cancer()
Gene expression is extensively and dynamically modulated at the level of translation. How cancer cells prioritize the translation of certain mRNAs over others from a pool of competing mRNAs remains an open question. Here, we analyze translation in cell line models of breast cancer and normal mammary...
Autores principales: | Vaklavas, Christos, Blume, Scott W., Grizzle, William E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948383/ https://www.ncbi.nlm.nih.gov/pubmed/31911279 http://dx.doi.org/10.1016/j.tranon.2019.12.002 |
Ejemplares similares
-
Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development
por: Vaklavas, Christos, et al.
Publicado: (2017) -
Small molecule inhibitors of IRES-mediated translation
por: Vaklavas, Christos, et al.
Publicado: (2015) -
Translational control of the undifferentiated phenotype in ER-positive breast tumor cells: Cytoplasmic localization of ERα and impact of IRES inhibition
por: Vaklavas, Christos, et al.
Publicado: (2018) -
IRES inhibition induces terminal differentiation and synchronized death in triple-negative breast cancer and glioblastoma cells
por: Vaklavas, Christos, et al.
Publicado: (2016) -
Relaxed initiation pausing of ribosomes drives oncogenic translation
por: Dong, Leiming, et al.
Publicado: (2021)